Tuberculosis remains one of the top 10 causes of death globally, particularly in regions with high TB burden and limited access to healthcare services. In 2022, 1.3 million people died of TB, and 10.6 million people fell ill with the disease.
In recent years the context has improved. We have witnessed an increased access of people to TB services, promising scientific progress, renewed political will and improved coordination among stakeholders, giving hope to eradicate a disease that is both preventable and curable.
However, to pursue this path and make sure it actually delivers game-changing tools to the fight against TB by 2030, efforts need to be intensified and the international community has the responsibility to sustain the recent momentum.
In the run-up to World TB Day 2024, which takes place each year on March 24th, Global Health Advocates releases a brief paper advocating for France and the EU to increase their funding for TB R&D.
;
